Antimicrobial host defense in the upper gastrointestinal tract

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 12, 2008, Pages 1151-1158

  Hosaka, Yoshio ^a,c,d   Koslowski, Maureen ^a   Nuding, Sabine ^a   Wang, Guoxing ^a   Schlee, Miriam ^a   Schäfer, Christian ^b   Saigenji, Katunori ^d   Stange, Eduard F ^b   Wehkamp, Jan ^a,b,e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c Department of Internal Medicine   (Japan)

^d KITASATO UNIVERSITY   (Japan)

^e DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

Antimicrobial peptide; Defensin; Elafin; Oesophagus; Psoriasin

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 5; ALPHA DEFENSIN 6; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; ELAFIN; MESSENGER RNA; PSORIASIN; TISSUE EXTRACT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DUODENUM BIOPSY; ESCHERICHIA COLI; ESOPHAGUS BIOPSY; FUNGUS ISOLATION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; MUCOSA INFLAMMATION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BIOPSY; UPPER GASTROINTESTINAL TRACT;

ALPHA-DEFENSINS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CALCIUM-BINDING PROTEINS; CANDIDA ALBICANS; CARRIER PROTEINS; DEFENSINS; ELAFIN; ESCHERICHIA COLI; ESOPHAGUS; HUMANS; PANETH CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; UPPER GASTROINTESTINAL TRACT;

EID: 56749157692     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283052ddb     Document Type: Article

References (30)

1. Schroder JM, Epithelial antimicrobial peptides: innate local host response elements. Cell Mol Life Sci 1999; 56:32-46.
2. Bevins C, Porter EM, Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut 1999; 45:911-915.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415:389-395.
4. Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13:61-92.
5. Ouellette AJ. Defensin-mediated innate immunity in the small intestine. Best Pract Res Clin Gastroenterol 2004; 18:405-419.
6. Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A 2002; 99:3902-3907.
7. Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett 1999; 452: 309-313.
8. Tollin M, Bergman P, Svenberg T, Jornvall H, Gudmundsson GH, Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 2003; 24:523-530.
9. Kiehne K, Brunke G, Meyer D, Harder J, Herzig KH. Oesophageal defensin expression during Candida infection and reflux disease. Scand J Gastroenterol 2005; 40:501-507.
10. Pfundt R, van RF, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, et al. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest 1996; 98:1389-1399.
11. Wehkamp J, Fellermann K, Herrlinger K, Bevins C, Stange EF. Mechanisms of Disease: defensins in gastrointestinal diseases. Nature Clin Pract 2005; 2:406-415.
12. Putsep K, Cartsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002; 360:1144-1149.
13. Islam DF, Bandholtz LF, Nilsson JF, Wigzell HF, Christensson BF, Agerberth BF, Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a n immune escape mechanism with bacterial DNA as a potential regulato. Nat Med 2001; 7:180-185.
14. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79:439-448.
15. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sei U S A 2005; 102:18129-18134.
16. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal aipha-defensin expression. Gut 2004; 53:1658-1664.
17. Wehkamp J, Wang G, Kubier I, Nuding S, Gregorieff A, Schnabel A, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179:3109-3118.
18. Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, Lee SK, Bevins CL. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 2006; 580:5344-5350.
19. Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol 2007; 81:907-915.
20. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005; 6:57-64.
21. Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14:745-752.
22. Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 2007; 56:1240-1247.
23. Wehkamp J, Schauber J, Stange EF. Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 2007; 23:32-38.
24. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schröder JM. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000; 22:714-721.
25. Wehkamp J, Harder J, Wehkamp K, Wehkamp V, Meissner B, Schlee M, Enders C. NF-kB and AP-1 mediated induction of human beta defensin-2 in intestinal epithelial cells by E. coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004; 72:5750-5758.
26. Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163:6718-6724.
27. Vora P, Youdim A, Thomas LS, Fukata M, Tesfay SY, Lukasek K, et al. beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004; 173:5398-5405.
28. Wehkamp J, Schmidt K, Herrlinger KR, Baxmann S, Behling S, Wohlschlager C, et al. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003; 56:352-357.
29. Shen B, Porter EM, Reynoso E, Shen C, Ghosh D, Connor JT, et al. Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract. J Clin Pathol 2005; 58:687-694.
30. Frohm NM, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999; 67:2561-2566.